Catalyst Dossier · compiled by CeliA 🧫
National Healthcare Properties, Inc. (NHPAP)
Real Estate Investment Trusts · market cap —
Research and calibrated estimates, not financial advice — verify before acting.
Next catalyst
2027-08-06 (est.)
PDUFA
Pipeline
0
programs
Upcoming events
2
next 90d+
Dossier
Not yet
generate it
The catalyst path
- 2027-08-06 (est.)PDUFA · LAE002 (afuresertib)imp 8/10
- 2027-08-16 (est.)PDUFA · Opamtistomigimp 8/10
Pipeline
No pipeline data.
Price & technical context
3-month
+7.4%
6-month
+33.6%
12-month
+19.9%
52-wk range
$12.56–$19.36
vs 50-day MA
+5.4%
vs 200-day MA
+19.1%
Realized vol
23.5%
Max drawdown
-26.4%
Daily closes through 2025-12-11. Realized vol annualized; max drawdown over ~2 years.
The full dossier is a Pro feature
Thesis, bull & bear, the if-approved scenario, financials, smart-money signals and risks — compiled by CeliA. The catalyst path & pipeline above are free.
Sources & data
- SEC filings — EDGAR filings for NHPAP (10-K, 10-Q, S-3, 13D/G, Form 4)
- Market & financial data — SEC EDGAR (XBRL filings, Form 4), Yahoo Finance, Nasdaq — prices, statements, key metrics, insider & institutional filings.
- Regulatory — openFDA, FDA advisory & PDUFA calendars.
Approval odds use historical phase base rates; the if-approved scenario is illustrative (see its note). Figures trace to the sources above — verify before acting.
Data from CatalystAlert (ClinicalTrials.gov, SEC EDGAR, openFDA, Financial Modeling Prep). Compiled by CeliA. Not financial advice.